Cuba's Center for Genetic Engineering and Biotechnology (CIGB) has registered the first recombinant monoclonal antibody to be used in the production of an anti-hepatitis B vaccine.
CIGB Deputy Director General Carlos Borroto described it as a true world scientific breakthrough, and it was obtained after having completed all necessary stages of the technological process required for it.
Advertisement
At a press conference in Havana, Borroto said it was the result of research work similar to what is being developed by research teams from dozens of highly developed nations.
Baptized as CB-Hep.1, the recombinant monoclonal antibody made of plants is of great relevance to increase the production of the anti-hepatitis B vaccine at a lower cost.
From the research point of view, this breakthrough leaves a door opened to obtain other effective antibodies to fight illnesses, including cancer.
(Source:PTI News)
From the research point of view, this breakthrough leaves a door opened to obtain other effective antibodies to fight illnesses, including cancer.
(Source:PTI News)
Advertisement
Advertisement
|
Advertisement
Latest General Health News
Implementing the Hawk Data Pro system as a passive surveillance tool enabled us to record an ongoing rabies outbreak within a major Indian metropolis.
The Pakistan Ministry has announced the commencement of a nationwide polio vaccination campaign beginning on October 2, aiming to immunize more children.
In a tragic incident, a woman in the US experienced the loss of all her limbs as a result of a bacterial outbreak linked to the consumption of contaminated fish.
FluMos-v2, a unique universal influenza vaccine candidate, undergoing a phase 1 trial at NIH, increases recipients' immunity against many influenza viruses.
In Pakistan, the polio campaign focuses on more than 270,000 children under the age of five years, residing in areas with insufficient vaccine coverage.
